HY-N9965-5mg
|
MedChemexpress LLC
|
2'-Fucosyllactose [CAS 41263-94-9]
|
|
COVID-19-immunoregulation
|
|
HY-N1942-1mg
|
MedChemexpress LLC
|
5-O-Demethylnobiletin [CAS 2174-59-6]
|
|
COVID-19-immunoregulation
|
|
HY-N1942-10mg
|
MedChemexpress LLC
|
5-O-Demethylnobiletin [CAS 2174-59-6]
|
|
COVID-19-immunoregulation
|
|
HY-N1942-20mg
|
MedChemexpress LLC
|
5-O-Demethylnobiletin [CAS 2174-59-6]
|
|
COVID-19-immunoregulation
|
|
HY-N1942-5mg
|
MedChemexpress LLC
|
5-O-Demethylnobiletin [CAS 2174-59-6]
|
|
COVID-19-immunoregulation
|
|
HY-N4126-10mg
|
MedChemexpress LLC
|
6-Demethoxytangeretin [CAS 6601-66-7]
|
|
COVID-19-immunoregulation
|
|
HY-N4126-5mg
|
MedChemexpress LLC
|
6-Demethoxytangeretin [CAS 6601-66-7]
|
|
COVID-19-immunoregulation
|
|
HY-N2609-10mg
|
MedChemexpress LLC
|
7,4'-Dihydroxyflavone [CAS 2196-14-7]
|
|
COVID-19-immunoregulation
|
|
HY-N2609-5mg
|
MedChemexpress LLC
|
7,4'-Dihydroxyflavone [CAS 2196-14-7]
|
|
COVID-19-immunoregulation
|
|
HY-N2609-50mg
|
MedChemexpress LLC
|
7,4'-Dihydroxyflavone [CAS 2196-14-7]
|
|
COVID-19-immunoregulation
|
|
HY-N2609-1mL
|
MedChemexpress LLC
|
7,4'-Dihydroxyflavone [CAS 2196-14-7] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-P1110-1mg
|
MedChemexpress LLC
|
AF12198 [CAS 185413-30-3]
|
|
COVID-19-immunoregulation
|
|
HY-P1110-5mg
|
MedChemexpress LLC
|
AF12198 [CAS 185413-30-3]
|
|
COVID-19-immunoregulation
|
|
HY-120878-10mg
|
MedChemexpress LLC
|
CXCR2-IN-2 [CAS 1838123-21-9]
|
|
COVID-19-immunoregulation
|
|
HY-120878-100mg
|
MedChemexpress LLC
|
CXCR2-IN-2 [CAS 1838123-21-9]
|
|
COVID-19-immunoregulation
|
|
HY-120878-25mg
|
MedChemexpress LLC
|
CXCR2-IN-2 [CAS 1838123-21-9]
|
|
COVID-19-immunoregulation
|
|
HY-120878-5mg
|
MedChemexpress LLC
|
CXCR2-IN-2 [CAS 1838123-21-9]
|
|
COVID-19-immunoregulation
|
|
HY-120878-50mg
|
MedChemexpress LLC
|
CXCR2-IN-2 [CAS 1838123-21-9]
|
|
COVID-19-immunoregulation
|
|
HY-120878-1mL
|
MedChemexpress LLC
|
CXCR2-IN-2 [CAS 1838123-21-9] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-128583-1mg
|
MedChemexpress LLC
|
G150 [CAS 2369751-30-2]
|
|
COVID-19-immunoregulation
|
|
HY-128583-10mg
|
MedChemexpress LLC
|
G150 [CAS 2369751-30-2]
|
|
COVID-19-immunoregulation
|
|
HY-128583-100mg
|
MedChemexpress LLC
|
G150 [CAS 2369751-30-2]
|
|
COVID-19-immunoregulation
|
|
HY-128583-25mg
|
MedChemexpress LLC
|
G150 [CAS 2369751-30-2]
|
|
COVID-19-immunoregulation
|
|
HY-128583-5mg
|
MedChemexpress LLC
|
G150 [CAS 2369751-30-2]
|
|
COVID-19-immunoregulation
|
|
HY-128583-50mg
|
MedChemexpress LLC
|
G150 [CAS 2369751-30-2]
|
|
COVID-19-immunoregulation
|
|